Skip to content
lifestyle.friendhood.net
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
BriaCell Therapeutics Corp.
BriaCell and BriaPro to Present Four Posters at SITC 2026 Annual Meeting
October 6, 2026
Data Safety Monitoring Board (DSMB) Recommends Continuing BriaCell’s Phase 3 Metastatic Breast Cancer Study
September 14, 2026
BriaCell Phase 3 Metastatic Breast Cancer Trial Expands to MSK
September 8, 2026
BriaCell Advances Personalized Melanoma Immunotherapy Vaccine Candidate, Bria-MEL+™
August 24, 2026
BriaCell Receives FDA Clearance to Initiate Bria-PROS+™ Clinical Study in Prostate Cancer
August 5, 2026
BriaCell Opens First Canadian Site – Sunnybrook – for Pivotal Phase 3 Trial in Metastatic Breast Cancer
July 16, 2026
BriaCell Arranges Scalable Manufacturing with FUJIFILM Biotechnologies for Bria-IMT™
July 15, 2026
BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™
July 7, 2026
BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™
June 25, 2026
BriaCell Adds NYU Langone Health’s Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study
May 7, 2026
1
2
Next Page
→